On ECHEMI
Home > Drugs > Hubei Biocause Heilen Pharmaceutical Co., Ltd.
Hubei Biocause Heilen Pharmaceutical Co., Ltd.
  • Founded in:

    1995-12-29
  • Country:

    China China
  • Address:

    No. 122, Yangwan Road, Duodao District, Jingmen City
  • Tax NO.:

    91420800615406429F
  • Registered Funds:

    288 million yuan
  • Website:

  • Email:

Related Drugs
Trimethoprim-sulfamethoxazole tablets
This product is a compound preparation, each tablet contains sulfamethoxazole, sulfadiazine and trimethoprim
Name Description Content CAS NO. Registered Holders
sulfamethoxazole,SMZ

0
Sulfadiazine

68-35-9 14
Trimethoprim

738-70-5 44
Ibuprofen tablets
The main component and chemical name of this product are: 2-(4-isobutylphenyl) propionic acid. Molecular formula: C13H18O2 Molecular weight: 206.28
Name Description Content CAS NO. Registered Holders
Ibuprofen

It has analgesic, anti-inflammatory and antipyretic effects. Its mechanism of action is to reduce the synthesis of prostaglandins by inhibiting cyclooxygenase, thereby alleviating tissue congestion and swelling caused by prostaglandins and reducing the sensitivity of peripheral nerve pain. It has an antipyretic effect through the hypothalamic temperature regulation center.

More

It has analgesic, anti-inflammatory and antipyretic effects. Its mechanism of action is to reduce the synthesis of prostaglandins by inhibiting cyclooxygenase, thereby alleviating tissue congestion and swelling caused by prostaglandins and reducing the sensitivity of peripheral nerve pain. It has an antipyretic effect through the hypothalamic temperature regulation center.

15687-27-1 54
Compound acetylsalicylic acid tablets
Acetylsalicylic acid.
Name Description Content CAS NO. Registered Holders
Acetylsalicylic acid

Analgesic, anti-inflammatory, antipyretic, anti-rheumatic, inhibiting platelet aggregation

More

Analgesic, anti-inflammatory, antipyretic, anti-rheumatic, inhibiting platelet aggregation

50-78-2 35
Chlorpheniramine Maleate Tablets
Each tablet of this product contains the main ingredient chlorpheniramine maleate 4 mg Chemical name: Chlorpheniramine maleate Molecular formula: C20H23ClN2O4 Molecular weight: 390.87
Name Description Content CAS NO. Registered Holders
Chlorphenamine maleate

As a histamine H1 receptor antagonist, this product can counteract capillary dilation caused by allergic reactions, reduce capillary permeability, and relieve wheezing caused by bronchial smooth muscle contraction. This product has a long-lasting antihistamine effect and also has a significant central inhibitory effect, which can increase the effects of anesthetics, analgesics, hypnotics and local anesthetics. This product is mainly metabolized in the liver.

More

As a histamine H1 receptor antagonist, this product can counteract capillary dilation caused by allergic reactions, reduce capillary permeability, and relieve wheezing caused by bronchial smooth muscle contraction. This product has a long-lasting antihistamine effect and also has a significant central inhibitory effect, which can increase the effects of anesthetics, analgesics, hypnotics and local anesthetics. This product is mainly metabolized in the liver.

4mg 113-92-8 28
Nifedipine Tablets
The main ingredient of this product is nitrophenylpyridine.
Name Description Content CAS NO. Registered Holders
Nifedipine

By blocking the membrane transport of calcium ions in myocardial and vascular smooth muscle, inhibiting the influx of calcium ions into cells, it causes a decrease in myocardial contractility and vasodilation. Animal experiments have shown that by reducing myocardial contractility and peripheral vascular resistance, myocardial oxygen consumption is reduced; by dilating coronary vessels and developing collateral circulation, the oxygen supply to myocardial ischemic sites is increased; by inhibiting the consumption of high-energy phosphate compounds, the ability to resist hypoxia is enhanced.

More

By blocking the membrane transport of calcium ions in myocardial and vascular smooth muscle, inhibiting the influx of calcium ions into cells, it causes a decrease in myocardial contractility and vasodilation. Animal experiments have shown that by reducing myocardial contractility and peripheral vascular resistance, myocardial oxygen consumption is reduced; by dilating coronary vessels and developing collateral circulation, the oxygen supply to myocardial ischemic sites is increased; by inhibiting the consumption of high-energy phosphate compounds, the ability to resist hypoxia is enhanced.

21829-25-4 74
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.